McKinsey supports EspeRare enhancing its impact for patients
McKinsey supported EspeRare to think through its business model by defining its innovative value proposition and growth priorities. As part of a longstanding partnership with Ashoka, an organization which identifies and support social entrepreneurs, McKinsey has worked with Esperare to enhance the delivery of its highly distinctive approach and to maximize its impact for patients. The consulting company also applied knowledge and experience to support the foundation in the development of a methodology to assess its qualitative and quantitative public health impact.
McKinsey & Company is a management consulting firm that helps leading organizations across the globe to improve their performance.
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.